These findings suggest that, in ILC, angiogenesis activation, although essential for tumour growth and progression, does not need VEGF overexpression but should be promoted through angiogenic factors others than VEGF, which might be HIF-1α-dependent. The gene discussed is CCL27; the disease is neoplasm.